Quick Takeaways
- Lance Friedman filed SCHEDULE 13G/A for Aspire Biopharma Holdings, Inc. Common Stock (ASBP).
- Disclosed ownership: 8.6%.
- Date of event: 04 Apr 2025.
Lance Friedman - 04 Apr 2025 SCHEDULE 13G/A Report for Aspire Biopharma Holdings, Inc. Common Stock (ASBP)
- Filing Manager
- Lance Friedman
- Reporting Manager
- Lance Friedman
- Symbol
- ASBP
- Shares outstanding
- 48,928,363 shares
- Disclosed Ownership
- 4,183,375 shares
- Ownership
- 8.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 11 Apr 2025, 16:55:30 UTC
- Date of event
- 04 Apr 2025
- Previous filing
- 04 Apr 2025
- Next filing
- 17 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Lance Friedman disclosed 8.6% ownership in Aspire Biopharma Holdings, Inc. Common Stock (ASBP) on 04 Apr 2025."
What Changed
- Previous schedule filing date: 04 Apr 2025.
- Current filing was accepted on 11 Apr 2025, 16:55.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lance Friedman | 8.6% | 4,183,375 | 4,183,375 | 0 | /s/ Lance Friedman | Lance Friedman |